6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Latest Press Releases

Time	Headline
Just now	Quarterly Activities Report - March 2026
13m ago	Appendix 4C and Quarterly Activities Report - March 2026
39m ago	Diagens Annual Results: 100B-Parameter Model Reshapes Medical AI Landscape; Licensing Revenue Becomes Primary Growth Engine
39m ago	ING completes share buyback and announces new programme of up to €1.0 billion
39m ago	argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026

About

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK) — investor relations, events, news, and company updates on 6ix.

Latest News

Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026

Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series

Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as a Highly Expressed, Clinically Relevant Target for Gynecologic Cancers at SGO 2026

Whitehawk Therapeutics to Highlight its Next-Generation ADC Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026

Whitehawk Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Highlights

Financials

Revenue

$7.14 M

Market Cap

$165.66 M

EPS

-0.33

Community Chat

Ask AI

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern